Focus on ophthalmology and expansion of clinical areas and facilities
First written in FY2018. 14 of 23 entries say "Advanced", first in FY2018. Latest entry: 2026-08-07.
0 other companies' latest entry also says "Restated".
- FY2025Decline in the number of surgeries due to intensifying competition and countermeasuresAnnual report
「Although the number of LASIK surgeries performed by SLACC in Metro Manila declined during the fiscal year amid intensifying competition, customers continue to rate highly the medical services incorporating Japanese technology and expertise, and the company will continue working to provide high-quality services.」
The full-year results state that the number of LASIK surgeries declined because of intensifying competition, while the company continues to focus on ophthalmology and provide high-quality services. - FY2025-H1RestatedAnnual report
「SLACC’s core LASIK business continues to be affected by intensifying competition. The company is continuing efforts to carefully review its marketing methods and service structure in order to provide LASIK services on a stable basis.」
The company reaffirmed its policy of continuing to review its marketing methods and service structure and provide stable services in its ophthalmology business centered on LASIK, despite the impact of intensifying competition. - FY2024-Q1AdvancedAnnual report
「At SLACC, which performs LASIK and other procedures, the number of patient visits increased as a result of promoting safe operations with thorough coronavirus infection-prevention measures.」
SLACC continues safe operations with thorough infection-prevention measures and reported an increase in patient visits. - FY2023-Q3AdvancedAnnual report
「In the Medical & Healthcare Business during the nine months ended 31 December, the number of LASIK procedures, SLACC’s core service, continued to increase. To further expand the business, the company began expansion work at its Ortigas clinic.」
In addition to an increase in LASIK procedures, the company began expansion work at its existing Ortigas clinic, giving concrete form to the expansion of its treatment capacity and business scale. - FY2023-Q2AdvancedAnnual report
「Shinagawa Lasik & Aesthetics Center Corporation (hereinafter, “SLACC”), which operates clinics in Metro Manila, has implemented thorough COVID-19 prevention measures so that customers can receive treatment with confidence, and the number of LASIK procedures has increased substantially year on year.」
While continuing infection-prevention measures, SLACC reported a substantial year-on-year increase in the number of LASIK procedures. - FY2023-Q1AdvancedAnnual report
「Shinagawa Lasik & Aesthetics Center Corporation (hereinafter, “SLACC”), which operates clinics in Metro Manila, has implemented thorough COVID-19 prevention measures so that customers can receive treatment with confidence, and the number of patient visits has increased substantially year on year.」
The company continues to operate 3 clinics and implement infection-prevention measures, reporting a substantial year-on-year increase in patient visits at SLACC. - FY2022AdvancedAnnual report
「The business is recovering sharply as a result of thorough COVID-19 measures, with the number of surgeries reaching a record high.」
The company reported that the number of LASIK surgeries reached a record high while maintaining 3 clinics and implementing infection-prevention measures. - FY2022-Q3AdvancedAnnual report
「At SLACC, thorough measures against COVID-19 and safe operations were well received by customers, increasing the number of LASIK procedures and driving a strong recovery in earnings despite the challenging business environment.」
Thorough infection-control measures and safe operations increased the number of LASIK procedures. Revenue in the Medical and Beauty Business was ¥831 million, and segment profit was ¥256 million. - FY2022-Q2AdvancedAnnual report
「In the Medical and Beauty Business during the six months ended 30 September, the impact of COVID-19 continued, but at Shinagawa Lasik & Aesthetics Center Corporation, patient visits recovered and LASIK procedures performed well as a result of safe operations with thorough preventive measures. As a result, revenue was ¥522 million, up 144.0% year on year, and segment profit was ¥156 million, up 574.2%.」
Patient visits recovered and LASIK procedures performed well as a result of operations with thorough infection-prevention measures. Revenue in the Medical and Beauty Business was ¥522 million, and segment profit was ¥156 million. - FY2022-Q1AdvancedAnnual report
「During the quarter, we prioritized COVID-19 prevention measures and maintained safe operations, enabling us to meet customer needs and resulting in a recovery trend in patient visits. As a result, revenue was ¥246 million, up 47.1% year on year, and segment profit was ¥83 million, up 110.9%.」
The company maintained 3 clinics and prioritized COVID-19 measures in its operations, resulting in a recovery trend in patient visits. Revenue in the Medical and Beauty Business was ¥246 million, and segment profit was ¥83 million. - FY2021-Q3RestatedAnnual report
「During the nine months ended 31 December, Shinagawa Lasik & Aesthetics Center Corporation opened a hospital primarily serving high-income customers in Bonifacio Global City, an emerging city in Metro Manila, in March 2020. However, Metro Manila entered lockdown in mid-March due to the spread of COVID-19, forcing all 3 clinics operated by the company to close until the end of May. After the lockdown was lifted, the company resumed offering LASIK and other procedures while implementing measures against COVID-19, focusing on the Bonifacio clinic, which has a spacious waiting room and makes it easier to maintain social distancing.」
The company continues to operate 3 clinics, including the Bonifacio clinic, and focus on ophthalmology. After the lockdown, it resumed procedures, centered on the Bonifacio clinic, while implementing infection-control measures. - FY2020AchievedAnnual report
「Demand for myopia correction has been strong. As bank loans and other financing have made the procedure accessible to more people, adding capacity for myopia-correction surgery has become an important management priority, and we opened our third clinic in March this year.」
The company reported that it opened its third clinic in Bonifacio Global City in March 2020, following the earlier opening plan. Full-year revenue in the Medical and Beauty Business was ¥872 million, and segment profit was ¥268 million. - FY2020-Q3SoftenedAnnual report
「We currently operate 2 clinics in Metro Manila, but will open a new hospital in Bonifacio Global City, an emerging city in Metro Manila, primarily serving high-income customers. We plan to enhance customer satisfaction and increase average spending per customer through high-quality service. The hospital is scheduled to open in March 2020.」
The company stated plans to open a facility for high-income customers in Bonifacio Global City as its third clinic, specializing in myopia-correction surgery. The stated opening date changed from February 2020 to March 2020. - FY2020-Q2RestatedAnnual report
「We currently operate 2 clinics in Metro Manila, but will open a new hospital in Bonifacio Global City, an emerging city in Metro Manila, primarily serving high-income customers. We plan to enhance customer satisfaction and increase average spending per customer through high-quality service. A grand opening is planned for February 2020.」
The company continues to plan the opening of a hospital for high-income customers in Bonifacio Global City, with high-quality service intended to increase customer satisfaction and average spending per customer. The opening is scheduled for February 2020. - FY2020-Q1AdvancedAnnual report
「We currently operate 2 clinics in Metro Manila, but will open a new hospital in Bonifacio Global City, an emerging city in Metro Manila, primarily serving high-income customers. We plan to enhance customer satisfaction and increase average spending per customer through high-quality service. A soft opening is planned for 2019, followed by full-scale operations from early 2020.」
The plan progressed from operating 2 clinics in Metro Manila to opening a new hospital for high-income customers in Bonifacio Global City. A soft opening is planned for 2019, with full-scale operations scheduled to begin in early 2020. - FY2019AdvancedAnnual report
「We conducted active sales activities, including promotions in partnership with banks that issue credit cards and with insurers offering health insurance programs for major companies. We also continued efforts to raise awareness of our myopia-correction surgery by having public figures share their LASIK experiences on social media.」
Under its policy of focusing on ophthalmology, the company conducted promotional campaigns in partnership with banks and insurers, as well as campaigns featuring public figures sharing their experiences on social media. - FY2019-Q3RestatedAnnual report
「In the Medical and Beauty Business, myopia-correction LASIK procedures have continued to perform well. Cataract treatment was also launched in January 2018 to attract new customers. In addition, the company is working to expand its customer base by strengthening digital marketing and through other measures. Going forward, it plans to expand its medical equipment and facilities to meet demand, including through enhanced safety and an increase in the number of patients.」
The company continues its policy of expanding medical equipment and facilities, along with the strong performance of LASIK, cataract treatment launched in January 2018 and customer-base expansion through digital marketing. - FY2019-Q2AdvancedAnnual report
「In the Medical and Beauty Business, myopia-correction LASIK surgeries have continued to perform well. Cataract treatment was also launched in January 2018 to attract new customers. In addition, the company is working to expand its customer base by strengthening digital marketing and through other measures. Going forward, it plans to expand its medical equipment and facilities to meet demand, including through enhanced safety and an increase in the number of patients.」
In addition to its existing policy on LASIK, cataract treatment and expanding medical equipment, the company stated that it would expand its customer base by strengthening digital marketing. - FY2019-Q1RestatedAnnual report
「In the Medical and Beauty Business, LASIK procedures have continued to perform well, and cataract treatment was launched in January 2018 to attract new customers. Going forward, the company plans to expand its medical equipment and facilities to meet demand.」
The company reiterates the strong performance of LASIK, the launch of cataract treatment in January 2018 and its policy of expanding medical equipment and facilities. - FY2018AdvancedAnnual report
「We will add cataract treatment to myopia-correction surgery (LASIK), specialize in ophthalmology, and expand revenue by investing further in this area.」
Cataract surgery began in January 2018, and plans are also in place to expand medical equipment for LASIK and cataract treatment.